Stability Study of Mucoadhesive Microsphere Containing Nateglinide by Using Biodegradable Polymer Chitosan
Varun Dasari, Anis Shaikh, Dharmesh Sisodiya, Tanu Bhargava, Rameshwar Dangi, Sunil Nagwe, Sharuk L. Khan, Falak A. Siddiqui
Journal of Pharmaceutical Research International · pp. 866–872 · Published 30 Oct 2021
10.9734/jpri/2021/v33i47A33086Abstract
Aim: Stability Study of Mucoadhesive Microsphere Containing Nateglinide by Using Biodegradable Polymer Chitosan Study Design: The investigation of the stability of Nateglindine containing mucoadhesive microsphere by using chitosan was carried out. Methodology: The present study was performed to test the stability of microspheres formulation. The promising formulations were selected for in-vitro stability studies. Formulations were stored in screw-capped, amber color small glass bottles at 4±1°C, 27±2°C, and 42 ± 2°C for 45 days. After 0, 15, 30, and 45 days they were evaluated for the following parameters like particle size, and percent residual drug content. Results: The particle size of the microspheres was found to increase slightly at 4±1°C from initial to 45 days which might be due to the agglomeration of particles. While at a higher temperature that is 27±2°C, an increased in particle size was observed to more as compared to particle stored at 4±1°C could be due to agglomeration of microspheres more at a higher temperature. As the period passed, the concentration of the drug in the formulation was decreased with time but at the highest (42±2°C) temperature degradation rate was maximum. Conclusions: The stability study of microsphere containing Nateglinide concludes that the formulation CM-4326F was the best formulation in drug stability studies. As the period passed, the concentration of the drug in the formulation was decreased with time but at the highest (42±2°C) temperature degradation rate was maximum. Hence it was concluded that temperature 4±1°C or 27±2°C are suitable for storage of formulation because little changed was found in particle size and residual drug content.
Cited by 4
Shubhangi Aher, Aparna Jain, Dipti Solanki · Journal of Drug Delivery and Therapeutics · 2024
Haldia Institute of Pharmacy, Hatiberia, Purba Medinipur, West Bengal, India, Mahua Bera, Suman Pattanayak · International Journal of Drug Delivery Technology · 2025
LALITA S. NEMADE, MORESHWAR P. PATIL · International Journal of Applied Pharmaceutics · 2023
Jaydeep Narendra Dusane, Ashok Vitthal Bhosale · International journal of health sciences · 2022
Related research
- Herbal Approach towards the Cure of Diabetes Mellitus— A Review — shares topic coverage
- Hematological Indices in Alloxan-Induced Diabetic Rats: Effect of Supplementation with the Antioxidant Dimethyl Sulfoxide — shares topic coverage
- Analysis of Risk Factors among Diabetic Patients Visiting Diabetic Research Clinic at Nishtar Hospital Multan-Pakistan — shares topic coverage
- Prevalence of Hypertension among Diabetic Patients in Benghazi: A Study of Associated Factors — shares topic coverage
- Visfatin Level in Diabetic and Non-diabetic Chronic Kidney Diseases — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
4
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.